SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017661
Filing Date
2016-05-04
Accepted
2016-05-04 16:22:48
Documents
46
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20160331.htm 10-Q 1071664
2 EX-31.1 nktr-ex311_10.htm EX-31.1 16066
3 EX-31.2 nktr-ex312_9.htm EX-31.2 16064
4 EX-32.1 nktr-ex321_8.htm EX-32.1 7757
  Complete submission text file 0001564590-16-017661.txt   3561852

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20160331.xml EX-101.INS 532136
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20160331.xsd EX-101.SCH 40121
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20160331_cal.xml EX-101.CAL 43084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20160331_def.xml EX-101.DEF 88644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20160331_lab.xml EX-101.LAB 271905
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20160331_pre.xml EX-101.PRE 190252
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 161619690
SIC: 2834 Pharmaceutical Preparations